Clinical Trial Update: Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing T2347 to Xalacom in ocular hypertensive or glaucomatous patients has completed with results posted, evaluating efficacy and safety of th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• T2347
• Xalacom (latanoprost/timolol)

Snippet

Sponsor: Laboratoires Thea | Conditions: Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2017-01-23